The Swiss group NOVARTIS has taken over the British firm LAGAP PHARMA (£27 million turnover in 2000 with 70 staff), specialised in generic medicines, from the South African group ADCOCK INGRAM. LAGAP will be tied to NOVARTIS GENERICS (CHF 1.9 bn turnover in 2000).